Literature DB >> 31211828

Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.

Veronica L Hood1, Ralph Berger1, Robert Freedman1, Amanda J Law1,2,3.   

Abstract

PIK3CD encodes the phosphoinositide 3-kinase (PI3K) catalytic subunit, p110δ, a lipid kinase linked to neurodevelopmental disorders, including schizophrenia (SZ). PIK3CD is regulated at the transcript level through alternate use of 5' untranslated exons (UTRs), promoters, and proinflammatory cytokines. Increases in global PIK3CD expression and downregulation by neuroleptics are observed in SZ, and preclinical efficacy of a p110δ-selective inhibitor is seen in rodent models of risk. Here, we cloned PIK3CD alternative transcripts in human brain and evaluated temporal- and tissue-specific expression. We quantified PIK3CD transcripts in B-lymphoblastoid cells from patients with SZ and examined 5' UTR transcriptional regulation by tumor necrosis factor α (TNFα) and interleukin-1β (IL1β) in patient-derived fibroblasts. We report that PIK3CD transcripts are differentially expressed in human brain in a developmental-specific manner. Transcripts encoding 5' UTRs -2A and alternative exon -1 (Alt1), P37 and AS1 and AS2 were increased in SZ. Alt1, P37, and AS2 were also preferentially expressed in fetal brain, and all transcripts were regulated by TNFα and IL1β. Our findings provide novel insight into the complexity of PIK3CD regulation in human brain, implicate PIK3CD in human neurodevelopment, and identify isoform-specific disruption in SZ.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 31211828      PMCID: PMC6859435          DOI: 10.1093/hmg/ddz144

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Complete sequencing and characterization of 21,243 full-length human cDNAs.

Authors:  Toshio Ota; Yutaka Suzuki; Tetsuo Nishikawa; Tetsuji Otsuki; Tomoyasu Sugiyama; Ryotaro Irie; Ai Wakamatsu; Koji Hayashi; Hiroyuki Sato; Keiichi Nagai; Kouichi Kimura; Hiroshi Makita; Mitsuo Sekine; Masaya Obayashi; Tatsunari Nishi; Toshikazu Shibahara; Toshihiro Tanaka; Shizuko Ishii; Jun-ichi Yamamoto; Kaoru Saito; Yuri Kawai; Yuko Isono; Yoshitaka Nakamura; Kenji Nagahari; Katsuhiko Murakami; Tomohiro Yasuda; Takao Iwayanagi; Masako Wagatsuma; Akiko Shiratori; Hiroaki Sudo; Takehiko Hosoiri; Yoshiko Kaku; Hiroyo Kodaira; Hiroshi Kondo; Masanori Sugawara; Makiko Takahashi; Katsuhiro Kanda; Takahide Yokoi; Takako Furuya; Emiko Kikkawa; Yuhi Omura; Kumi Abe; Kumiko Kamihara; Naoko Katsuta; Kazuomi Sato; Machiko Tanikawa; Makoto Yamazaki; Ken Ninomiya; Tadashi Ishibashi; Hiromichi Yamashita; Katsuji Murakawa; Kiyoshi Fujimori; Hiroyuki Tanai; Manabu Kimata; Motoji Watanabe; Susumu Hiraoka; Yoshiyuki Chiba; Shinichi Ishida; Yukio Ono; Sumiyo Takiguchi; Susumu Watanabe; Makoto Yosida; Tomoko Hotuta; Junko Kusano; Keiichi Kanehori; Asako Takahashi-Fujii; Hiroto Hara; Tomo-o Tanase; Yoshiko Nomura; Sakae Togiya; Fukuyo Komai; Reiko Hara; Kazuha Takeuchi; Miho Arita; Nobuyuki Imose; Kaoru Musashino; Hisatsugu Yuuki; Atsushi Oshima; Naokazu Sasaki; Satoshi Aotsuka; Yoko Yoshikawa; Hiroshi Matsunawa; Tatsuo Ichihara; Namiko Shiohata; Sanae Sano; Shogo Moriya; Hiroko Momiyama; Noriko Satoh; Sachiko Takami; Yuko Terashima; Osamu Suzuki; Satoshi Nakagawa; Akihiro Senoh; Hiroshi Mizoguchi; Yoshihiro Goto; Fumio Shimizu; Hirokazu Wakebe; Haretsugu Hishigaki; Takeshi Watanabe; Akio Sugiyama; Makoto Takemoto; Bunsei Kawakami; Masaaki Yamazaki; Koji Watanabe; Ayako Kumagai; Shoko Itakura; Yasuhito Fukuzumi; Yoshifumi Fujimori; Megumi Komiyama; Hiroyuki Tashiro; Akira Tanigami; Tsutomu Fujiwara; Toshihide Ono; Katsue Yamada; Yuka Fujii; Kouichi Ozaki; Maasa Hirao; Yoshihiro Ohmori; Ayako Kawabata; Takeshi Hikiji; Naoko Kobatake; Hiromi Inagaki; Yasuko Ikema; Sachiko Okamoto; Rie Okitani; Takuma Kawakami; Saori Noguchi; Tomoko Itoh; Keiko Shigeta; Tadashi Senba; Kyoka Matsumura; Yoshie Nakajima; Takae Mizuno; Misato Morinaga; Masahide Sasaki; Takushi Togashi; Masaaki Oyama; Hiroko Hata; Manabu Watanabe; Takami Komatsu; Junko Mizushima-Sugano; Tadashi Satoh; Yuko Shirai; Yukiko Takahashi; Kiyomi Nakagawa; Koji Okumura; Takahiro Nagase; Nobuo Nomura; Hisashi Kikuchi; Yasuhiko Masuho; Riu Yamashita; Kenta Nakai; Tetsushi Yada; Yusuke Nakamura; Osamu Ohara; Takao Isogai; Sumio Sugano
Journal:  Nat Genet       Date:  2003-12-21       Impact factor: 38.330

2.  RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression.

Authors:  Emilie Lalonde; Kevin C H Ha; Zibo Wang; Amandine Bemmo; Claudia L Kleinman; Tony Kwan; Tomi Pastinen; Jacek Majewski
Journal:  Genome Res       Date:  2010-12-20       Impact factor: 9.043

3.  Specific expression of long noncoding RNAs in the mouse brain.

Authors:  Tim R Mercer; Marcel E Dinger; Susan M Sunkin; Mark F Mehler; John S Mattick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-09       Impact factor: 11.205

4.  Elevated serum levels of TNF-α, IL-6 and IL-18 in chronic schizophrenic patients.

Authors:  Yayan Luo; Hongbo He; Minling Zhang; Xini Huang; Jie Zhang; Yanling Zhou; Xianguo Liu; Ni Fan
Journal:  Schizophr Res       Date:  2014-09-22       Impact factor: 4.939

5.  Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Schizophr Res       Date:  2015-03-04       Impact factor: 4.939

6.  A simplified method to quantify dysregulated tyrosine transport in schizophrenia.

Authors:  Rodolfo Bongiovanni; Sherry Leonard; George E Jaskiw
Journal:  Schizophr Res       Date:  2013-09-17       Impact factor: 4.939

Review 7.  The contribution of alternative splicing to genetic risk for psychiatric disorders.

Authors:  E Reble; A Dineen; C L Barr
Journal:  Genes Brain Behav       Date:  2017-12-06       Impact factor: 3.449

8.  Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.

Authors:  Amanda J Law; Yanhong Wang; Yoshitatsu Sei; Patricio O'Donnell; Patrick Piantadosi; Francesco Papaleo; Richard E Straub; Wenwei Huang; Craig J Thomas; Radhakrishna Vakkalanka; Aaron D Besterman; Barbara K Lipska; Thomas M Hyde; Paul J Harrison; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

9.  Genetic variation and gene expression across multiple tissues and developmental stages in a nonhuman primate.

Authors:  Anna J Jasinska; Ivette Zelaya; Susan K Service; Christine B Peterson; Rita M Cantor; Oi-Wa Choi; Joseph DeYoung; Eleazar Eskin; Lynn A Fairbanks; Scott Fears; Allison E Furterer; Yu S Huang; Vasily Ramensky; Christopher A Schmitt; Hannes Svardal; Matthew J Jorgensen; Jay R Kaplan; Diego Villar; Bronwen L Aken; Paul Flicek; Rishi Nag; Emily S Wong; John Blangero; Thomas D Dyer; Marina Bogomolov; Yoav Benjamini; George M Weinstock; Ken Dewar; Chiara Sabatti; Richard K Wilson; J David Jentsch; Wesley Warren; Giovanni Coppola; Roger P Woods; Nelson B Freimer
Journal:  Nat Genet       Date:  2017-10-30       Impact factor: 38.330

10.  Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.

Authors:  Ashwini C Poopal; Lindsay M Schroeder; Paul S Horn; Gary J Bassell; Christina Gross
Journal:  Mol Autism       Date:  2016-01-14       Impact factor: 7.509

View more
  4 in total

1.  p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.

Authors:  Ramón Martínez-Mármol; Nika Mohannak; Lei Qian; Tong Wang; Rachel S Gormal; Marc J Ruitenberg; Bart Vanhaesebroeck; Elizabeth J Coulson; Frédéric A Meunier
Journal:  J Neurosci       Date:  2019-07-30       Impact factor: 6.167

2.  Early onset senescence and cognitive impairment in a murine model of repeated mTBI.

Authors:  Nicole Schwab; YoungJun Ju; Lili-Naz Hazrati
Journal:  Acta Neuropathol Commun       Date:  2021-05-08       Impact factor: 7.801

3.  Activated PI3Kδ syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model.

Authors:  Ines Serra; Olivia R Manusama; Fabian M P Kaiser; Izi Izumi Floriano; Lucas Wahl; Christian van der Zalm; Hanna IJspeert; P Martin van Hagen; Nico J M van Beveren; Sandra M Arend; Klaus Okkenhaug; Johan J M Pel; Virgil A S H Dalm; Aleksandra Badura
Journal:  Brain Behav Immun Health       Date:  2021-10-19

Review 4.  PI3K inhibitors are finally coming of age.

Authors:  Bart Vanhaesebroeck; Matthew W D Perry; Jennifer R Brown; Fabrice André; Klaus Okkenhaug
Journal:  Nat Rev Drug Discov       Date:  2021-06-14       Impact factor: 112.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.